ARCHIVES

Clinical Trial System Inefficient, UPCI Director Tells Senate

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

Samuels Says Industry Should Pay For Valium Carcinogenicity Tests

March 20, 1981

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

NIH Study Sections Use New Scoring Procedure

July 3, 1998

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012